º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Chinese pharmaceutical giant Pharmaron to create 174 Liverpool jobs after securing £151m investment

A total of £277m has been awarded through the grants

Pharmaron's Liverpool base is located at Estuary Commerce Park(Image: Pharmaron)

A Chinese pharmaceutical giant is to be handed £151m to substantially grow its operations in Liverpool and create 174 jobs.

Pharmaron has been named as one of the beneficiaries of the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants backed by the government and private investment.

The company will now increase its production capacity for critical gene therapy and vaccine components four-fold as well a secure as further 156 roles.

READ MORE: Click here to sign up to the BusinessLive North West newsletter

A total of £277m has been awarded through the grants, with £17m coming from the government and £260m from the private sector.

The grants are said to be helping to create 320 jobs and safeguard 199 roles.

Elsewhere, Ipsen has been awarded £75m to grow the manufacture of innovative medicines for neurological conditions, creating 39 new jobs and safeguarding a further 37 at its Wrexham facility.

Touchlight has been handed £14m to create 17 jobs and protect a further six at its London base.